Skip to main content

Dalbavancin IV

Permitted Indications

Only on the advice of a Medical Microbiologist or Infection Specialist for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in adults for:

  1. 2nd line use or when Meticillin-Resistant Staphylococcus Aureus (MRSA) infection is suspected.


Where the patient is initially hospitalised due to ABSSSI, requires intravenous antibiotics, but is eligible for early discharge as soon as their medical condition does not require further inpatient treatment.

Not licensed for use in children.